Aptamers are single-stranded DNA or RNA molecules with immense potential in diagnostics and therapeutics. Their unique binding properties enable them to target and bind to specific proteins with high affinity and specificity. Unlike traditional antibodies, aptamers can be synthesized in vitro, making them more cost-effective and customizable.
The utility of aptamers doesn’t stop at diagnostics. They hold great promise in targeted drug delivery and therapeutic applications. As a result, Opprtna Therapeutics is leading the charge in aptamer-based treatment solutions.
Talking about limitations, aptamers aren’t perfect. They can face problems like rapid degradation and poor cellular uptake. However, scientists are working to overcome these challenges and unlock the true potential of aptamers.
Xeno Nucleic Acids: Key Publications
2022
2021
2020
2019
